Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study
Open accessThe DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Optimal glycaemia, reflected by glycated haemoglobin (HbA1c) levels, is key in reducing type 2 diabetes (T2D) complications. However, most people with T2D have suboptimal recall and understanding of HbA1c. Continuous glucose monitoring (CGM) measures glucose levels every 5 to 15-min over days and may be more readily understood. Given that T2D is more common in lower socioeconomic settings, we aim to study relationships between socioeconomic status (SES) and percentage time in glucose target range (TIR) which is a key metric calculated from CGM. METHODS: Analysis of baseline data from the General Practice Optimising Structured MOnitoring To Improve Clinical outcomes (GP-OSMOTIC) randomised controlled trial (October 2016 - November 2017) of 300 people with T2D from 25 Victorian General Practices. FreeStyle Libre Pro® sensor patch was used for this study. SES was defined by the Index of Relative Socio-economic Disadvantage (IRSD) and educational attainment. Univariable and multivariable mixed-effects linear regression analyses controlling for age, BMI, diet, exercise and study arm were performed. RESULTS: One hundred and sixty-seven (60.1%) participants were male, the mean (SD) participant age was 61.0 (9.7) years, and the mean (SD) duration of CGM use was 12.3 (2.5) days. The 10th IRSD decile (least disadvantaged) was associated with a 15% higher TIR vs. the 1st decile (most disadvantaged) (95% CI 5, 25; p = 0.003) and a 0.6% lower HbA1c (95% CI 0.1, 1; p = 0.03). There was no evidence of an association between educational attainment and TIR/HbA1c. CONCLUSION: Higher SES measured at an area level is associated with better achievement of glycaemic target using complementary measures of HbA1c and TIR in the GP-OSMOTIC cohort. Given that TIR may be more easily used in patient education and self-management support compared to HbA1c values, the social gradient identified in TIR provides an opportunity for clinicians and policy makers to address health inequities in T2D. TRIAL REGISTRATION: Australian and New Zealand Clinical Trials Registry Trial ACTRN12616001372471 , prospective, Date registered 4/10/2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Cognitive behavioral therapy delivered by trained mental health personnel, either face to face or through virtual web-based media, is effective in reducing depression and improving self-care and DM outcomes.1645–1647,1649,1650”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1649]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01064-k · Cited by 3,079
Scott, T. L., Gazmararian, J. A., Williams, M. V., & Baker, D. W. (2002) · Medical Care · doi:10.1097/00005650-200205000-00005 · Cited by 744
Heisler, M., Piette, J. D., Spencer, M., Kieffer, E., & Vijan, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.816 · Cited by 326
Schillinger, D., Barton, L. R., Karter, A. J., Wang, F., & Adler, N. (2006) · Public Health Reports® · doi:10.1177/003335490612100305 · Cited by 295
Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement
Johnson, D. W., Jones, G. R. D., Mathew, T. H., Ludlow, M. J., Chadban, S. J., Usherwood, T., Polkinghorne, K., Colagiuri, S., Jerums, G., MacIsaac, R., et al. (2012) · Medical Journal of Australia · doi:10.5694/mja11.11468 · Cited by 231
Bachmann, M. O., Eachus, J., Hopper, C. D., Davey Smith, G., Propper, C., Pearson, N. J., Williams, S., Tallon, D., & Frankel, S. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01050.x · Cited by 184
Research works printed but not linked: 1
- Pink B: Technical paper: socio-economic indexes for areas (SEIFA). 2013.
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Health Care Disparities in Use of Continuous Glucose Monitoring
Isaacs, D., Bellini, N. J., Biba, U., Cai, A., & Close, K. L. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0268 · Cited by 61
“Disparities in socioeconomic status and time in glucose target range were reported by Tan et al. 26 in their analysis of the General Practice Optimizing Structured MOnitoring To Improve Clinical outcomes (GPOSMOTIC) randomized controlled trial.”
Kieu, A., King, J., Govender, R. D., & Östlundh, L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211070855 · Cited by 73
Furler, J., O'Neal, D., Speight, J., Blackberry, I., Manski-Nankervis, J.-A., Thuraisingam, S., de La Rue, K., Ginnivan, L., Doyle, R., Holmes-Truscott, E., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30385-7 · Cited by 55
Self-citationTime-in-range as a target in type 2 diabetes: An urgent need
Saboo, B., Kesavadev, J., Shankar, A., Krishna, M. B., Sheth, S., Patel, V., & Krishnan, G. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05967 · Cited by 44
“The study revealed that the least disadvantaged group of patients was associated with a 15% higher TIR compared to the most disadvantaged group and asserted the efficacy of TIR to discourse the disparities in T2D prevalence and developing patient education and self-management support plans [22].”
Background
Metadata
- Authors
- Tan, M. L., Manski-Nankervis, J.-A., Thuraisingam, S., Jenkins, A., O’Neal, D., & Furler, J.
- Affiliations
- The University of Melbourne (AU)
- The University of Sydney (AU)
- Corresponding author
- Manski-Nankervis, Jo-Anne
- Venue
- BMC Endocrine Disorders
- Published
- 2018-07-21
- Volume
- 18
- Issue
- 1
- Pages
- 47-47
- ISSN
- 1472-6823 (ISSN-L)
- PMC
- PMC6054739
- OpenAlex
- W2883045301
- Cited by
- 14
- References
- 27
- Citations by year
- 2025: 1 · 2024: 2 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 1
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Endocrine Disorders (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Sanofi
- Australian Government
- Royal Australian College of General Practitioners
- Abbott Diabetes Care
- Medical Research Council
- National Health and Medical Research Council (1104241)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, socioeconomic status, continuous glucose monitoring, HbA1c, glycemic control, social gradient, health disparities, educational attainment, FreeStyle Libre Pro, self-management support, patient education, general practitioner care, diabetes complications prevention
- MeSH terms
- Aged, Australia, Blood Glucose, Diabetes Mellitus, Type 2, Drug Administration Schedule, Female, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Patient Care Planning, Self Care, Social Class, Time Factors, Blood Glucose Self-Monitoring, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study. https://app.cochat.ai/papers/10.1186/s12902-018-0279-6
- The paper
- Tan, M. L., Manski-Nankervis, J.-A., Thuraisingam, S., Jenkins, A., O’Neal, D., & Furler, J. (2018). Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-018-0279-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.